In a phone interview, Huber shared that he believes his experience with Google, in different areas over 13 years, set him up to be very conscious of analytics and looking at specific data, which will be an asset to Grail in determining the efficacy of future clinical trials.
Also, CTI BioPharma Corp said the U.S Food and Drug Administration has put a full clinical hold on the company's investigational new drug application for pacritinib.
Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.
Google X's life science division is being spun out as a brand new company, according to a restructuring announcement from Alphabet's Sergey Brin.
TOP STORIES A Harvard cardiologist has moved over to Google’s research arm Google X to lead the Baseline study announced last year to do the biggest deep dive of what it means to be healthy down to molecules and cells. Meet Elpidera, a new Moderna spinoff that will target rare genetic diseases using Moderna’s messenger […]
Never mind telemedicine as a replacement for a doctor visit. Google X wants to create a pill that will not only find health problems when they first start to develop but do all the lab work for you as well. Andrew Conrad, head of the Life Sciences team at the Google X research lab, announced […]